ArticleAmerican journal of cancer research2020

RBMX contributes to hepatocellular carcinoma progression and sorafenib resistance by specifically binding and stabilizing BLACAT1.

Yanan Song et al.PubMed ↗Full text ↗

No numbers read from the abstract.